Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification

Tetralogy of Fallot (TOF) is a common congenital heart malformation. Genetic variants in the CITED2 coding region are known to be significantly associated with cardiac malformation, but the role of variants in the CITED2 promoter region in the development of TOF remains unclear. In this study, we in...

Full description

Bibliographic Details
Main Authors: Zhuo Chen, Huan-Xin Chen, Hai-Tao Hou, Xiu-Yun Yin, Qin Yang, Guo-Wei He
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/12/11/1644
_version_ 1827647112566800384
author Zhuo Chen
Huan-Xin Chen
Hai-Tao Hou
Xiu-Yun Yin
Qin Yang
Guo-Wei He
author_facet Zhuo Chen
Huan-Xin Chen
Hai-Tao Hou
Xiu-Yun Yin
Qin Yang
Guo-Wei He
author_sort Zhuo Chen
collection DOAJ
description Tetralogy of Fallot (TOF) is a common congenital heart malformation. Genetic variants in the CITED2 coding region are known to be significantly associated with cardiac malformation, but the role of variants in the CITED2 promoter region in the development of TOF remains unclear. In this study, we investigated CITED2 promoter variants in the DNA of 605 subjects, including 312 TOF patients and 293 unrelated healthy controls, by Sanger sequencing. We identified nine CITED2 gene promoter variants (including one novel heterozygous variant). Six were found only in patients with TOF and none in the control group. The transcriptional activity of the CITED2 gene promoter in mouse cardiomyocyte (HL-1) cells was significantly altered by the six variants (<i>p</i> < 0.05). The results of the electrophoretic mobility change assay and JASPAR database analysis showed that these variants generated or destroyed a series of possible transcription factor binding sites, resulting in changes in the CITED2 protein expression. We conclude that CITED2 promoter variants in TOF patients affect transcriptional activity and may be involved in the occurrence and progression of TOF. These findings may provide new insights into molecular pathogenesis and potential therapeutic insights in patients with TOF.
first_indexed 2024-03-09T19:14:40Z
format Article
id doaj.art-e2b3b76817824adc8353c1f0387b310d
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-09T19:14:40Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-e2b3b76817824adc8353c1f0387b310d2023-11-24T03:53:55ZengMDPI AGBiomolecules2218-273X2022-11-011211164410.3390/biom12111644Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function VerificationZhuo Chen0Huan-Xin Chen1Hai-Tao Hou2Xiu-Yun Yin3Qin Yang4Guo-Wei He5The Institute of Cardiovascular Diseases & Department Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Tianjin University & Chinese Academy of Medical Sciences, Tianjin 300457, ChinaThe Institute of Cardiovascular Diseases & Department Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Tianjin University & Chinese Academy of Medical Sciences, Tianjin 300457, ChinaThe Institute of Cardiovascular Diseases & Department Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Tianjin University & Chinese Academy of Medical Sciences, Tianjin 300457, ChinaThe Institute of Cardiovascular Diseases & Department Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Tianjin University & Chinese Academy of Medical Sciences, Tianjin 300457, ChinaThe Institute of Cardiovascular Diseases & Department Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Tianjin University & Chinese Academy of Medical Sciences, Tianjin 300457, ChinaThe Institute of Cardiovascular Diseases & Department Cardiovascular Surgery, TEDA International Cardiovascular Hospital, Tianjin University & Chinese Academy of Medical Sciences, Tianjin 300457, ChinaTetralogy of Fallot (TOF) is a common congenital heart malformation. Genetic variants in the CITED2 coding region are known to be significantly associated with cardiac malformation, but the role of variants in the CITED2 promoter region in the development of TOF remains unclear. In this study, we investigated CITED2 promoter variants in the DNA of 605 subjects, including 312 TOF patients and 293 unrelated healthy controls, by Sanger sequencing. We identified nine CITED2 gene promoter variants (including one novel heterozygous variant). Six were found only in patients with TOF and none in the control group. The transcriptional activity of the CITED2 gene promoter in mouse cardiomyocyte (HL-1) cells was significantly altered by the six variants (<i>p</i> < 0.05). The results of the electrophoretic mobility change assay and JASPAR database analysis showed that these variants generated or destroyed a series of possible transcription factor binding sites, resulting in changes in the CITED2 protein expression. We conclude that CITED2 promoter variants in TOF patients affect transcriptional activity and may be involved in the occurrence and progression of TOF. These findings may provide new insights into molecular pathogenesis and potential therapeutic insights in patients with TOF.https://www.mdpi.com/2218-273X/12/11/1644tetralogy of FallotCITED2geneticcardiac
spellingShingle Zhuo Chen
Huan-Xin Chen
Hai-Tao Hou
Xiu-Yun Yin
Qin Yang
Guo-Wei He
Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification
Biomolecules
tetralogy of Fallot
CITED2
genetic
cardiac
title Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification
title_full Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification
title_fullStr Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification
title_full_unstemmed Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification
title_short Pathophysiological Role of Variants of the Promoter Region of CITED2 Gene in Sporadic Tetralogy of Fallot Patients with Cellular Function Verification
title_sort pathophysiological role of variants of the promoter region of cited2 gene in sporadic tetralogy of fallot patients with cellular function verification
topic tetralogy of Fallot
CITED2
genetic
cardiac
url https://www.mdpi.com/2218-273X/12/11/1644
work_keys_str_mv AT zhuochen pathophysiologicalroleofvariantsofthepromoterregionofcited2geneinsporadictetralogyoffallotpatientswithcellularfunctionverification
AT huanxinchen pathophysiologicalroleofvariantsofthepromoterregionofcited2geneinsporadictetralogyoffallotpatientswithcellularfunctionverification
AT haitaohou pathophysiologicalroleofvariantsofthepromoterregionofcited2geneinsporadictetralogyoffallotpatientswithcellularfunctionverification
AT xiuyunyin pathophysiologicalroleofvariantsofthepromoterregionofcited2geneinsporadictetralogyoffallotpatientswithcellularfunctionverification
AT qinyang pathophysiologicalroleofvariantsofthepromoterregionofcited2geneinsporadictetralogyoffallotpatientswithcellularfunctionverification
AT guoweihe pathophysiologicalroleofvariantsofthepromoterregionofcited2geneinsporadictetralogyoffallotpatientswithcellularfunctionverification